Skip to main content

Research Repository

Advanced Search

All Outputs (2484)

Correlation of cartilage oligomeric matrix protein (COMP) levels in equine tendon with mechanical properties: a proposed role for COMP in determining function-specific mechanical characteristics of locomotor tendons.
Journal Article
Smith, R. K. W., Gerard, M., Dowling, B., Dart, A. J., Birch, H. L., & Goodship, A. E. Correlation of cartilage oligomeric matrix protein (COMP) levels in equine tendon with mechanical properties: a proposed role for COMP in determining function-specific mechanical characteristics of locomotor tendons. Equine Veterinary Journal, 34, 241-244

Early activation of the p42/p44(MAPK) pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism
Journal Article
Wyatt, A. W., Steinert, J. R., Wheeler-Jones, C. P. D., Morgan, A. J., Sugden, D., Pearson, J. D., Sobrevia, L., & Mann, G. E. Early activation of the p42/p44(MAPK) pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism. FASEB Journal, 16(12), 1584-1594. https://doi.org/10.1096/fj.01-0125com

Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson’s disease at Chr16q11.2 and on the MAPT H1 allele
Report
Soutar, M., Melandri, D., Annuario, E., Monaghan, A., Welsh, N., D’Sa, K., Guelfi, S., Zhang, D., Pittman, A., Trabzuni, D., Pan, K., Kia, D., Bictash, M., Gandhi, S., Houlden, H., Cookson, M., Wood, N., Singleton, A., Hardy, J., Whiting, P., …Plun-Favreau, H. Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson’s disease at Chr16q11.2 and on the MAPT H1 allele

Parkinson’s disease (PD) is a common incurable neurodegenerative disease. The identification of genetic variants via genome-wide association studies (GWAS) has considerably advanced our understanding of the PD genetic risk. Understanding the function... Read More about Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson’s disease at Chr16q11.2 and on the MAPT H1 allele.